{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:56:53Z","timestamp":1761541013656},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.yexcr.2010.09.011","type":"journal-article","created":{"date-parts":[[2010,9,28]],"date-time":"2010-09-28T08:51:32Z","timestamp":1285663892000},"page":"151-162","source":"Crossref","is-referenced-by-count":17,"title":["Membrane-associated signaling in human B-lymphoma lines"],"prefix":"10.1016","volume":"317","author":[{"given":"Sebastien","family":"Tauzin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidrun","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitri","family":"Burdevet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bettina","family":"Borisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel C.","family":"Hoessli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2010.09.011_bb0005","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrc839","article-title":"The phosphatidylinositol 3-kinase AKT pathway in human cancer","volume":"2","author":"Vivanco","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexcr.2010.09.011_bb0010","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1172\/JCI0215617","article-title":"STAT proteins and oncogenesis","volume":"109","author":"Bromberg","year":"2002","journal-title":"Clin. Invest."},{"key":"10.1016\/j.yexcr.2010.09.011_bb0015","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1023\/B:APPT.0000045801.15585.dd","article-title":"The PI3K-Akt pathway: its functions and alterations in human cancer","volume":"9","author":"Osaki","year":"2004","journal-title":"Apoptosis"},{"key":"10.1016\/j.yexcr.2010.09.011_bb0020","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex","volume":"307","author":"Sarbassov","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2010.09.011_bb0025","doi-asserted-by":"crossref","first-page":"C281","DOI":"10.1152\/ajpcell.00422.2003","article-title":"G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K\/AKT\/m TOR\/p70S6K1 signaling in human ovarian cancer cells","volume":"287","author":"Gao","year":"2004","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.yexcr.2010.09.011_bb0030","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0898-6568(01)00271-6","article-title":"The protein kinase B\/Akt signalling pathway in human malignancy","volume":"14","author":"Nicholson","year":"2002","journal-title":"Cell. Signal."},{"key":"10.1016\/j.yexcr.2010.09.011_bb0035","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bbapap.2007.10.003","article-title":"Targeting phosphoinositide 3-kinase: moving towards therapy","volume":"1784","author":"Marone","year":"2008","journal-title":"Biochim. Biophys. Acta: Proteins Proteomics"},{"key":"10.1016\/j.yexcr.2010.09.011_bb0040","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.4049\/jimmunol.178.4.2328","article-title":"Requirement for phosphoinositide 3-kinase p110delta signaling in B cell antigen receptor-mediated antigen presentation","volume":"178","author":"Al-Alwan","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexcr.2010.09.011_bb0045","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1182\/blood.V99.2.584","article-title":"Tyrosine phosphorylation of B-cell adaptor for phosphoinositide 3-kinase is required for Akt activation in response to CD19 engagement","volume":"99","author":"Inabe","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2010.09.011_bb0050","doi-asserted-by":"crossref","first-page":"42767","DOI":"10.1074\/jbc.M107194200","article-title":"Src family kinases mediate receptor-stimulated, phosphoinositide 3-kinase-dependent, tyrosine phosphorylation of dual adaptor for phosphotyrosine and 3-phosphoinositide-1 in endothelial and B cell lines","volume":"276","author":"Stephens","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2010.09.011_bb0055","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1182\/blood-2005-05-1859","article-title":"LIME acts as a transmembrane adapter mediating BCR-dependent B-cell activation","volume":"107","author":"Ahn","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2010.09.011_bb0060","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4049\/jimmunol.167.1.163","article-title":"The role of the CD19\/CD21 complex in B cell processing and presentation of complement-tagged antigens","volume":"167","author":"Cherukuri","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexcr.2010.09.011_bb0065","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nri726","article-title":"Lipid rafts and B-cell activation","author":"Pierce","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.yexcr.2010.09.011_bb0070","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.molimm.2004.04.008","article-title":"B cell antigen receptor signaling 101","volume":"41","author":"Dal Porto","year":"2004","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.yexcr.2010.09.011_bb0075","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1182\/blood-2006-05-026203","article-title":"Syk-dependent mTOR activation in follicular lymphoma cells","volume":"108","author":"Leseux","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2010.09.011_bb0080","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2141.2005.05883.x","article-title":"Comparative genome-wide profiling of post-transplant lymphoproliferative disorders and diffuse large B-cell lymphomas","volume":"132","author":"Rinaldi","year":"2006","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.yexcr.2010.09.011_bb0085","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1182\/blood-2007-07-100115","article-title":"Syk-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma","volume":"111","author":"Chen","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2010.09.011_bb0090","doi-asserted-by":"crossref","first-page":"5715","DOI":"10.4049\/jimmunol.176.10.5715","article-title":"Constitutive B cell receptor signaling is critical for basal growth of B lymphoma","volume":"176","author":"Gururajan","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexcr.2010.09.011_bb0095","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1182\/blood-2007-05-090985","article-title":"Oncogenic association of the Cbp\/PAG adaptor protein with the Lyn tyrosine kinase in human B-NHL rafts","volume":"111","author":"Tauzin","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2010.09.011_bb0100","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1152\/physiol.00032.2006","article-title":"Lipid rafts, detergent-resistant membranes, and raft targeting signals","volume":"21","author":"Brown","year":"2006","journal-title":"Physiology"},{"key":"10.1016\/j.yexcr.2010.09.011_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1026585006064","article-title":"Signaling through sphingolipid microdomains of the plasma membrane; the concept of signaling platform","volume":"17","author":"Hoessli","year":"2000","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.yexcr.2010.09.011_bb0110","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/35036052","article-title":"Lipid rafts and signal transduction","volume":"1","author":"Simons","year":"2000","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.yexcr.2010.09.011_bb0115","first-page":"221","article-title":"A new non-Hodgkin's B-cell line (DoHH2) with a chromosomal translocation t(14;18)(q32;q21)","volume":"5","author":"Kluin-Nelemans","year":"1991","journal-title":"Leukemia"},{"key":"10.1016\/j.yexcr.2010.09.011_bb0120","first-page":"534","article-title":"Anti-CD20 therapeutic antibody rituximab modifies the functional organization of rafts\/microdomains of B lymphoma cells","volume":"63","author":"Semac","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2010.09.011_bb0125","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1182\/blood-2006-04-016907","article-title":"Role of phosphatidylinositol 3\u2032-kinase\/AKT pathway in diffuse large B-cell lymphoma survival","volume":"108","author":"Uddin","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2010.09.011_bb0130","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1182\/blood-2006-04-015586","article-title":"Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma","volume":"108","author":"Rudelius","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2010.09.011_bb0135","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1371\/journal.ppat.0030166","article-title":"EBV latent membrane protein 1 activates Akt, NFkappaB, and Stat3 in B cell lymphomas","volume":"3","author":"Shair","year":"2007","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.yexcr.2010.09.011_bb0140","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1084\/jem.191.9.1591","article-title":"Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein kinase csk and is involved in regulation of T cell function","volume":"191","author":"Brdicka","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yexcr.2010.09.011_bb0145","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.cellsig.2006.12.003","article-title":"Critical role for lipid-associated Src kinases in activation of PI3K-Akt signalling","volume":"19","author":"Arcaro","year":"2007","journal-title":"Cell. Signal."},{"key":"10.1016\/j.yexcr.2010.09.011_bb0150","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/onc.2009.450","article-title":"Src family tyrosine kinases-driven colon cancer cell invasion is induced by Csk membrane delocalization","volume":"29","author":"Sirvent","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2010.09.011_bb0155","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1172\/JCI200522094","article-title":"Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis","volume":"115","author":"Contri","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yexcr.2010.09.011_bb0160","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1182\/blood-2007-04-082099","article-title":"A critical role for Lyn in acute myeloid leukemia","volume":"111","author":"Dos Santos","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2010.09.011_bb0165","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bbapap.2007.08.012","article-title":"Src family kinases: regulation of their activities, levels and identification of new pathways","volume":"1784","author":"Ingley","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.yexcr.2010.09.011_bb0170","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.1002\/j.1460-2075.1994.tb06897.x","article-title":"Identification of Src, Fyn, Lyn, PI3K and Abl SH3 domain ligands using phage display libraries","volume":"13","author":"Rickles","year":"1994","journal-title":"EMBO J."},{"key":"10.1016\/j.yexcr.2010.09.011_bb0175","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1091\/mbc.7.6.843","article-title":"Phosphoinositides and phosphoinositide-utilizing enzymes in detergent-insoluble lipid domains","volume":"7","author":"Hope","year":"1996","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.yexcr.2010.09.011_bb0180","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1038\/sj.emboj.7600655","article-title":"PIP2 signaling in lipid domains: a critical reevaluation","volume":"24","author":"van Rheenen","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.yexcr.2010.09.011_bb0185","first-page":"518","article-title":"Spatiotemporal analysis of differential Akt regulation in plasma membrane microdomains","volume":"10","author":"Gao","year":"2008","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.yexcr.2010.09.011_bb0190","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1182\/blood.V93.8.2645","article-title":"Genetic and pharmacological analyses of Syk function in alphaIIbbeta3 signaling in platelets","volume":"93","author":"Law","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2010.09.011_bb0195","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nri1808","article-title":"ITAM-mediated tonic signaling through pre-BCR and BCR complexes","volume":"6","author":"Monroe","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.yexcr.2010.09.011_bb0200","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1476-4598-8-132","article-title":"Anomalous constitutive Src kinase activity promotes B lymphoma survival and growth","volume":"8","author":"Ke","year":"2009","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.yexcr.2010.09.011_bb0205","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1124\/jpet.106.109058","article-title":"R406, an orally available spleen tyrosine kinase inhibitor blocks Fc receptor signaling abd reduces immune complex-mediated inflammation","volume":"319","author":"Braselmann","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.yexcr.2010.09.011_bb0210","doi-asserted-by":"crossref","first-page":"32650","DOI":"10.1074\/jbc.M806340200","article-title":"Molecular mechanism of the Syk activation switch","volume":"283","author":"Tsang","year":"2008","journal-title":"J. Biol. Chem."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482710004477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482710004477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T05:47:14Z","timestamp":1591940834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482710004477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0014482710004477"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2010.09.011","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}